Illumina Inc is a leading biotechnology company that specializes in the development and manufacturing of advanced genomic sequencing technologies
The company focuses on providing innovative solutions for researchers and healthcare professionals, enabling them to analyze DNA, RNA, and other genomic materials with high accuracy and efficiency. Illumina’s cutting-edge sequencing platforms and reagents support a wide range of applications, including genomics research, clinical diagnostics, and personalized medicine, thereby playing a crucial role in advancing the field of genomics and improving human health.
Shares of genomics company Illumina (NASDAQILMN) fell 6.3% in the afternoon session after China put the company on its "unreliable entity" list, opening the door to possible sanctions. The move came after the Trump administration slapped a 10% tariff on Chinese goods. Financial filings in 2024 revealed that Illumina makes about 7% of its sales from China, and it's unclear whether China's action is a short-term reaction or one with longer consequences.
U.S. stocks advanced midday Tuesday, demonstrating resilience despite escalating geopolitical tensions and trade uncertainties between the world’s two largest economies.
CD Genomics launches advanced mtDNA sequencing, enhancing genetic research by providing detailed insights into genetic diversity, maternal transmission, species relationships, and biodiversity conservation through cutting-edge technology.
Stock market gains during Dec. 24-Dec. 31 window, known as Santa Claus rally, averaging 0.85% return in 64 out of 96 years. 2018 saw strongest rally of 6.6%.
Holiday celebrations dampened by Fed's hawkish tone, sending shockwaves through markets. Santa Rally hopes crumble before Friday's inflation data, offering a glimmer of hope for a year-end rally.
Super Micro Computer's stock is trading below its 50-day moving average ahead of its removal from the Nasdaq 100 Index on Dec. 23, 2024. The company faces delisting concerns and is seeking to raise capital through PIPE funding.
